Pulike Biological Engineering, Inc. (SHA:603566)
12.59
-0.04 (-0.32%)
Dec 16, 2025, 10:35 AM CST
SHA:603566 Revenue
Pulike Biological Engineering had revenue of 263.58M CNY in the quarter ending September 30, 2025, a decrease of -5.39%. This brings the company's revenue in the last twelve months to 1.10B, up 1.65% year-over-year. In the year 2024, Pulike Biological Engineering had annual revenue of 1.04B, down -16.77%.
Revenue (ttm)
1.10B
Revenue Growth
+1.65%
P/S Ratio
3.91
Revenue / Employee
711.69K
Employees
1,551
Market Cap
4.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.04B | -210.13M | -16.77% |
| Dec 31, 2023 | 1.25B | 22.62M | 1.84% |
| Dec 31, 2022 | 1.23B | 131.50M | 11.97% |
| Dec 31, 2021 | 1.10B | 170.06M | 18.31% |
| Dec 31, 2020 | 928.51M | 265.32M | 40.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |